Junan Li

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Multiple Myeloma

Top Venues

Molecular pharmacology

Molecular carcinogenesis

This page only lists publications with an associated author ORCID identifier.

Publications

Xinyi Wang, Jessika Carvajal-Moreno, Xinyu Zhao, Junan Li, Victor A Hernandez, Jack C Yalowich, Terry S Elton
Circumvention of Topoisomerase II α Intron 19 Intronic Polyadenylation in Acquired Etoposide-Resistant Human Leukemia K562 Cells. Molecular pharmacology 106 (1) (2024)
Xinyi Wang, Jessika Carvajal-Moreno, Xinyu Zhao, Junan Li, Victor A Hernandez, Jack C Yalowich, Terry S Elton
Circumvention of Topoisomerase II α Intron 19 Intronic Polyadenylation in Acquired Etoposide-Resistant Human Leukemia K562 Cells. Molecular pharmacology 106 (1) (2024)
Xinyi Wang, Jessika Carvajal-Moreno, Xinyu Zhao, Junan Li, Victor A Hernandez, Jack C Yalowich, Terry S Elton
Circumvention of Topoisomerase II α Intron 19 Intronic Polyadenylation in Acquired Etoposide-Resistant Human Leukemia K562 Cells. Molecular pharmacology 106 (1) (2024)
Xinyi Wang, Jessika Carvajal-Moreno, Xinyu Zhao, Junan Li, Victor A Hernandez, Jack C Yalowich, Terry S Elton
Circumvention of Topoisomerase II α Intron 19 Intronic Polyadenylation in Acquired Etoposide-Resistant Human Leukemia K562 Cells. Molecular pharmacology 106 (1) (2024)
Xinyi Wang, Jessika Carvajal-Moreno, Xinyu Zhao, Junan Li, Victor A Hernandez, Jack C Yalowich, Terry S Elton
Circumvention of Topoisomerase IIα Intron 19 Intronic Polyadenylation (IPA) in Acquired Etoposide Resistant Human Leukemia K562 Cells . Molecular pharmacology (2024)
Ernest Duah, Nathan D Seligson, Avinash K Persaud, Quynh Dam, Navjot Pabla, James W Rocco, Junan Li, Ming J Poi
CDK4/6 and autophagy inhibitors synergize to suppress the growth of human head and neck squamous cell carcinomas. Molecular carcinogenesis (2023)
Avinash K Persaud, Junan Li, Jasmine A Johnson, Nathan Seligson, Douglas W Sborov, Ernest Duah, Yu Kyoung Cho, Danxin Wang, Mitch A Phelps, Craig C Hofmeister, Ming J Poi
XRCC1-mediated DNA repair is associated with progression-free survival of multiple myeloma patients after autologous stem cell transplant. Molecular carcinogenesis 58 (12) (2019)